Ross Weinreb
Stock Analyst at Goldman Sachs
(n/a)
# 4,491
Out of 4,497 analysts
2
Total ratings
n/a
Success rate
-45.51%
Average return
Main Sectors:
Top Industries:
1 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLMD Relmada Therapeutics | Maintains: Buy | $69 → $53 | $4.16 | +1,174.04% | 2 | Mar 24, 2022 |
Relmada Therapeutics
Mar 24, 2022
Maintains: Buy
Price Target: $69 → $53
Current: $4.16
Upside: +1,174.04%